Jakarta, CNBC Indonesia – The Composite Stock Price Index (IHSG) strengthened at the close of the first trading session Monday (23/11/2020) following positive news related to vaccines covering Asian stock exchanges.
Pfizer has officially filed an emergency use permit for the vaccine they developed with the US Food and Drug Administration (FDA). This is the first proposal submitted to the FDA for the emergency use of an anti-corona vaccine.
The majority of Asian stock markets rose, except for the Nikkei which fell 0.4% and Hong Kong’s Hang Seng which fell 0.2%. The highest gain was booked by the Indian stock exchange which jumped 1.8%.
In Indonesia, the stock exchange benchmark index also strengthened, namely by 0.89% or 49.5 points to 5,621.52. A total of 287 stocks rose, 143 fell, and 275 others did not experience price changes.
Foreign investors scored net purchases of Rp. 199.7 billion on the regular market, with a transaction value of Rp. 6.2 trillion for more than 12 thousand shares, with a transaction frequency of 571,000 times. Coupled with the negotiable and cash markets, foreigners entered Rp. 229.55 billion.
The biggest gain was contributed by shares of PT Bank Rakyat Indonesia Tbk (BBRI) by 5.5 points, after the state-owned bank’s shares rose 1.2% to 4,070 per unit, followed by shares of PT Telekomunikasi Indonesia Tbk (TLKM) which rose 1.9% to Rp. 3,280 and contributed to a 5.3 point rally against the JCI.
On the other hand, shares of PT Bank Central Asia Tbk (BBCA) were the leader in the correction by weakening 0.3% to Rp 32,900 and contributing to the decline in the JCI by 2.2 points. In second place was PT Indonesian Paradise Property Tbk (INPP) which fell 5.7% e Rp.665 per share and contributed to HSG correction of 0.4 points.
CNBC INDONESIA RESEARCH TEAM
(bag bag)
– .
